Search details
1.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Lancet
; 402(10408): 1133-1146, 2023 09 30.
Article
in English
| MEDLINE | ID: mdl-37499670
2.
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
Cancer Immunol Immunother
; 73(7): 124, 2024 May 10.
Article
in English
| MEDLINE | ID: mdl-38727837
3.
A pan-cancer analysis of collagen VI family on prognosis, tumor microenvironment, and its potential therapeutic effect.
BMC Bioinformatics
; 23(1): 390, 2022 Sep 27.
Article
in English
| MEDLINE | ID: mdl-36167487
4.
A yes-associated protein 1- Notch1 receptor positive feedback loop promotes breast cancer lung metastasis by attenuating the bone morphogenetic protein 4-SMAD family member 1/5 signaling.
Carcinogenesis
; 43(12): 1162-1175, 2022 12 31.
Article
in English
| MEDLINE | ID: mdl-36194598
5.
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
Lancet Oncol
; 22(7): 977-990, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34143971
6.
Camrelizumab plus oxaliplatin-based chemotherapy as first-line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial.
Int J Cancer
; 149(11): 1944-1954, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34309846
7.
BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer.
Exp Cell Res
; 392(2): 112034, 2020 07 15.
Article
in English
| MEDLINE | ID: mdl-32339606
8.
Apatinib Inhibits Angiogenesis in Intrahepatic Cholangiocarcinoma by Regulating the Vascular Endothelial Growth Factor Receptor-2/Signal Transducer and Activator of Transcription Factor 3/Hypoxia Inducible Factor 1 Subunit Alpha Signaling Axis.
Pharmacology
; 106(9-10): 509-519, 2021.
Article
in English
| MEDLINE | ID: mdl-34412054
9.
Attention-Based Fault-Tolerant Approach for Multi-Agent Reinforcement Learning Systems.
Entropy (Basel)
; 23(9)2021 Aug 31.
Article
in English
| MEDLINE | ID: mdl-34573757
10.
Identification of consensus sequence from matrix attachment regions and functional analysis of its activity in stably transfected Chinese hamster ovary cells.
J Cell Biochem
; 120(8): 13985-13993, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30957285
11.
Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway.
Cancer Sci
; 109(12): 3865-3873, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30259603
12.
Ribosome display and selection of single-chain variable fragments effectively inhibit growth and progression of microspheres in vitro and in vivo.
Cancer Sci
; 109(5): 1503-1512, 2018 May.
Article
in English
| MEDLINE | ID: mdl-29575477
13.
18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model.
Radiology
; 287(1): 137-145, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29232185
14.
[Ultrasound-guided microwave ablation with artificial pleural effusion for liver tumor adjacent to diaphragmatic dome].
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 42(2): 184-188, 2017 Feb 28.
Article
in Zh
| MEDLINE | ID: mdl-28255121
15.
Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients.
Int J Cancer
; 139(4): 928-37, 2016 Aug 15.
Article
in English
| MEDLINE | ID: mdl-27038145
16.
Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Mol Cancer
; 14: 28, 2015 Feb 03.
Article
in English
| MEDLINE | ID: mdl-25645291
17.
An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13- tumor cells.
Tumour Biol
; 36(10): 8167-75, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25990455
18.
[Informed consent right of the appraised individuals in forensic clinical examination].
Fa Yi Xue Za Zhi
; 31(1): 44-7, 2015 Feb.
Article
in Zh
| MEDLINE | ID: mdl-26058134
19.
Exosome-derived miR-23a-5p inhibits HCC proliferation and angiogenesis by regulating PRDX2 expression: MiR-23a-5p/PRDX2 axis in HCC progression.
Heliyon
; 10(1): e23168, 2024 Jan 15.
Article
in English
| MEDLINE | ID: mdl-38187319
20.
VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk.
Int J Biol Sci
; 20(2): 446-463, 2024.
Article
in English
| MEDLINE | ID: mdl-38169627